Today, the VP, Compliance of Select Medical (NYSE: SEM), Robert Breighner, sold shares of SEM for $61.81K.
Following Robert Breighner’s last SEM Sell transaction on May 19, 2017, the stock climbed by 4.1%.
See today’s analyst top recommended stocks >>
Based on Select Medical’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $1.25 billion and quarterly net profit of $32.63 million. In comparison, last year the company earned revenue of $1.11 billion and had a net profit of $15.36 million. SEM’s market cap is $2.42B and the company has a P/E ratio of 12.36. Currently, Select Medical has an average volume of 677.9K.
Based on 3 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $24.00, reflecting a -24.4% downside. Four different firms, including Credit Suisse and JMP Securities, currently also have a Sell rating on the stock.
The insider sentiment on Select Medical has been negative according to 50 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following segments: Specialty Hospitals, Outpatient Rehabilitation and Concentra. The Specialty Hospitals segment involves in providing long term acute care hospital services and inpatient acute rehabilitative hospital care.
